£42m ePharmacy investment to transform prescribing across Northern Ireland
Northern Ireland’s community pharmacy sector is set for one of its most significant digital transformations to date following confirmation of a £42 million investment to deliver electronic prescription transfer and a new digital clinical services platform.
The funding, announced as part of a wider £102.6 million public sector transformation package, will support the rollout of the ePharmacy Primary Care Digital Reform Programme, replacing Northern Ireland’s long-standing paper prescription system with a fully digital model. The move is expected to modernise pharmacy workflows, improve patient safety and create the digital foundations needed to expand the role of community pharmacy in primary care.
At present, more than 45 million prescription items are prescribed and dispensed annually across primary care in Northern Ireland, with community pharmacies continuing to rely heavily on paper-based systems. The new investment will enable prescriptions to be transferred electronically from prescribers directly to community pharmacies, significantly reducing administrative burden and helping to streamline the dispensing process.
Health Minister Mike Nesbitt described the project as a major step forward for healthcare delivery, highlighting its potential to improve patient experience and support wider reform across health and social care.
The Department of Health has positioned the initiative as a central part of its wider strategy to shift care closer to home through a strengthened neighbourhood model of care. Alongside electronic prescription transfer, the programme will introduce a new digital platform designed to support the delivery and management of clinical services through community pharmacy. This is expected to create greater opportunities for pharmacies to provide enhanced services while integrating more effectively with GP practices and wider primary care teams.
Chief Pharmaceutical Officer Cathy Harrison has described electronic prescription transfer and digital service infrastructure as essential enablers of future pharmacy reform, noting that the programme aligns closely with the ambitions of Northern Ireland’s Community Pharmacy Strategic Plan 2030. The strategic direction has long identified digitisation as critical to unlocking the profession’s full clinical potential and supporting a broader shift from secondary care into community settings.
For community pharmacy contractors, the investment is likely to be welcomed as a long-overdue commitment to modernising systems that many believe have lagged behind other UK nations. England, Scotland and Wales have all advanced electronic prescribing capabilities over recent years, leaving Northern Ireland under increasing pressure to accelerate its own digital transformation.
The announcement also carries wider implications for patient access, efficiency and service resilience. By reducing reliance on physical prescription handling, the programme is expected to improve accuracy, reduce delays and create capacity for pharmacy teams to focus more on direct patient care.
For Northern Ireland’s pharmacy sector, the £42 million commitment signals more than just a technology upgrade. It represents a clear recognition of community pharmacy’s central role in delivering accessible, neighbourhood-based healthcare and could mark the beginning of a new era for digitally enabled pharmacy services across the region.